Blackbaud (NASDAQ:BLKB) and BIO-key International (NASDAQ:BKYI) Head to Head Survey

BIO-key International (NASDAQ:BKYI – Get Free Report) and Blackbaud (NASDAQ:BLKB – Get Free Report) are both small-cap technology companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and valuation.

Valuation and Earnings

This table compares BIO-key International and Blackbaud”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BIO-key International $6.09 million 0.42 -$7.16 million ($4.11) -0.44
Blackbaud $1.13 billion 1.74 $114.97 million $3.20 13.50

Blackbaud has higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than Blackbaud, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

BIO-key International has a beta of 0.4, suggesting that its share price is 60% less volatile than the S&P 500. Comparatively, Blackbaud has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for BIO-key International and Blackbaud, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International 1 1 0 0 1.50
Blackbaud 0 3 2 0 2.40

Blackbaud has a consensus price target of $49.50, suggesting a potential upside of 14.61%. Given Blackbaud’s stronger consensus rating and higher possible upside, analysts plainly believe Blackbaud is more favorable than BIO-key International.

Profitability

This table compares BIO-key International and Blackbaud’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BIO-key International -50.01% -67.31% -40.28%
Blackbaud 13.12% 197.49% 6.33%

Institutional & Insider Ownership

26.5% of BIO-key International shares are owned by institutional investors. Comparatively, 94.2% of Blackbaud shares are owned by institutional investors. 4.0% of BIO-key International shares are owned by company insiders. Comparatively, 2.0% of Blackbaud shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Blackbaud beats BIO-key International on 13 of the 14 factors compared between the two stocks.

About BIO-key International

(Get Free Report)

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

About Blackbaud

(Get Free Report)

Blackbaud, Inc. provides cloud software solutions to nonprofits, foundations, education institutions, and healthcare organizations in the United States and internationally. The company offers fundraising and engagement solutions, such as Blackbaud Raiser's Edge NXT, Blackbaud CRM, Blackbaud eTapestry, Blackbaud Luminate Online, Blackbaud TeamRaiser, JustGiving, Blackbaud Fundraiser Performance Management, Blackbaud Guided Fundraising, and Blackbaud Altru; and financial management solutions comprising Blackbaud Financial Edge NXT, Blackbaud Tuition Management, and Blackbaud Financial Aid and Billing Management. It also provides grant and award management solutions, consisting of Blackbaud Grantmaking and Blackbaud Award Management; education solutions, such as Blackbaud Student Information System, Blackbaud Learning Management System, Blackbaud Enrollment Management System, and Blackbaud School Website System; social responsibility solutions, which includes YourCause GrantsConnect and YourCause CSRconnect, and EVERFI; Blackbaud Merchant Services and Blackbaud Purchase Cards payment services; and Blackbaud's Intelligence for Good solutions, as well as Data Health, Insights, and Performance solutions and services. The company sells its solutions and related services through its direct sales force. Blackbaud, Inc. was founded in 1981 and is headquartered in Charleston, South Carolina.

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.